<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01977534</url>
  </required_header>
  <id_info>
    <org_study_id>13-304</org_study_id>
    <nct_id>NCT01977534</nct_id>
  </id_info>
  <brief_title>To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels</brief_title>
  <acronym>ABSORB UK</acronym>
  <official_title>A Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb BVS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Vascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Vascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and clinical outcomes of the Absorb BVS
      for daily use in patients with de novo lesions in previously untreated vessels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABSORB UK registry is a prospective, single arm, post-market registry designed to:

        -  Provide ongoing post-market surveillance for documentation of safety and clinical
           outcomes of the Absorb Everolimus Eluting BVS System in daily percutaneous coronary
           intervention (PCI) practice per Instructions for Use (IFU, on-label use).

        -  Collect additional information (e.g. acute success) to evaluate handling and
           implantation of Absorb BVS by physicians under a wide range of commercial use conditions
           and following routine clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Acute Success: Device success (lesion based analysis)</measure>
    <time_frame>From the start of index procedure to end of index procedure</time_frame>
    <description>Achievement of a final in-scaffold residual diameter stenosis of &lt; 50% assessed by online quantitative angiography or visual estimation, using Absorb BVS and without a device deficiency. A device is considered to have failed if it did not meet the requirements of the definition for clinical device success.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute Success: Procedural success (patient based analysis)</measure>
    <time_frame>From the start of index procedure to end of index procedure</time_frame>
    <description>Achievement of a final in-scaffold diameter stenosis of &lt; 50% by online QCA or visual estimation using Absorb BVS, with or without any adjunctive devices, and without the occurrence of cardiac death, target vessel MI (Q-wave and non Q-wave MI), or repeat revascularization of the target lesion within 3 days of the index procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Death (Cardiovascular, Non-Cardiovascular)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Death (Cardiovascular, Non-Cardiovascular)</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Infarction (MI)</measure>
    <time_frame>1 year</time_frame>
    <description>Attributable to Q-wave MI (QMI), non-Q wave MI (NQMI), target vessel (TV), non-target vessel (NTV)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MI</measure>
    <time_frame>3 year</time_frame>
    <description>Attributable to Q-wave MI (QMI), non-Q wave MI (NQMI), target vessel (TV), non-target vessel (NTV)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Target Lesion Revascularization (TLR)</measure>
    <time_frame>1 year</time_frame>
    <description>all TLR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TLR</measure>
    <time_frame>3 year</time_frame>
    <description>all TLR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TLR</measure>
    <time_frame>1 year</time_frame>
    <description>clinically indicated (ID-TLR)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TLR</measure>
    <time_frame>3 year</time_frame>
    <description>ID-TLR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Target Vessel Revascularization (TVR)</measure>
    <time_frame>1 year</time_frame>
    <description>all TVR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TVR</measure>
    <time_frame>3 year</time_frame>
    <description>all TVR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TVR</measure>
    <time_frame>1 year</time_frame>
    <description>clinically indicated (ID-TVR)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TVR</measure>
    <time_frame>3 year</time_frame>
    <description>ID-TVR</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/All MI/ID-TLR (MACE)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/All MI/ID-TLR (MACE)</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))</measure>
    <time_frame>3 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Scaffold/Stent Thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>acute, sub-acute, late and very late</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scaffold/Stent Thrombosis</measure>
    <time_frame>1 year</time_frame>
    <description>Definite, Probable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scaffold/Stent Thrombosis</measure>
    <time_frame>3 year</time_frame>
    <description>acute, sub-acute, late and very late</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scaffold/Stent Thrombosis</measure>
    <time_frame>3 year</time_frame>
    <description>Definite, Probable</description>
  </primary_outcome>
  <other_outcome>
    <measure>Acute Procedural Analyses (all patients)</measure>
    <time_frame>During the implantation procedure</time_frame>
    <description>Access site (femoral, brachial, radial)
Lesion preparation (Lesion 1, 2, 3, etc.)
Balloon pre-dilatation (yes - Max balloon size/Max balloon pressure, Cutting balloon yes/no, Other yes/no)
Techniques used to adequately prepare the lesion (de-calcification techniques (Rotablator yes/no, Other yes/no))
Treatment parameters
CASS numbers
No. of scaffolds per analyzable lesion (Lesion 1, 2, 3, etc.)
Scaffold length (Lesion 1, Lesion 2, Lesion 3, etc.)
Lesion length (Lesion 1, Lesion 2, Lesion 3, etc.)
Bailout / bailout device (if bailout required)
Post-treatment of lesion?
Balloon post-dilatation (no, yes - Max balloon diameter/Max balloon pressures/balloon length)
Jailed side-branch (no, yes). If yes, treatment of jailed sidebranch? (no, yes)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1005</enrollment>
  <condition>Coronary Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Restenosis</condition>
  <arm_group>
    <arm_group_label>Absorb BVS</arm_group_label>
    <description>Subjects receiving Absorb BVS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Absorb BVS</intervention_name>
    <description>The Absorb BVS System is a bioresorbable poly(L-lactide) (PLLA) scaffold with a drug and bioresorbable polymer coating [formulation of everolimus in a bioresorbable poly(D,L-lactide) (PDLLA) coating].</description>
    <arm_group_label>Absorb BVS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from the general interventional cardiology population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The inclusion criteria must follow the most recent IFU which may include but are not
        limited to the following:

          -  Patient must be at least 18 years of age at the time of signing the Informed Consent
             Form

          -  Patient is to be treated for de novo lesions located in previously untreated vessels.

          -  Patient must agree to undergo all required follow-up visits and data collection.

        Exclusion Criteria:

        The exclusion criteria must follow the most recent IFU which may include but are not
        limited to the following:

          -  Inability to obtain a signed informed consent from potential patient.

          -  Patient belongs to a vulnerable population (per investigator's judgment, this also
             includes people with a direct link (hierarchical or financial benefit) to the registry
             Doctor or the registry Sponsor).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Baumbach</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bristol Heart institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan Veldhof</last_name>
    <role>Study Director</role>
    <affiliation>Clinical Science</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lister Hospital</name>
      <address>
        <city>Stevenage</city>
        <state>Hertfordshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basildon Hospital</name>
      <address>
        <city>Basildon</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glan Clwyd District General Hospital</name>
      <address>
        <city>Bodelwyddan</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Bournmouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sussex Cardiac Centre</name>
      <address>
        <city>Brighton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frimley Park Hospital</name>
      <address>
        <city>Frimley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barts Heart Centre</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwick Park Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brompton Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norfolk &amp; Norwich University Hospital</name>
      <address>
        <city>Norwich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Alexandra Hospital</name>
      <address>
        <city>Portsmouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2013</study_first_submitted>
  <study_first_submitted_qc>October 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2013</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bioabsorbable</keyword>
  <keyword>Coronary Stent</keyword>
  <keyword>Everolimus</keyword>
  <keyword>drug eluting stents</keyword>
  <keyword>stents</keyword>
  <keyword>angioplasty</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>total coronary occlusion</keyword>
  <keyword>coronary artery restenosis</keyword>
  <keyword>stent thrombosis</keyword>
  <keyword>vascular disease</keyword>
  <keyword>myocardial ischemia</keyword>
  <keyword>coronary artery stenosis</keyword>
  <keyword>CAD</keyword>
  <keyword>CAOD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Restenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

